Super-sensitive molecule system for biological signal amplification, detection method and application
By separating the walking chain from the trajectory chain and utilizing the self-folding structure of the hairpin probe H, the problem of false positive signals in complex biological samples by traditional DNA walking machines is solved, achieving highly specific and sensitive detection of biomolecules.
Patent Information
- Application Number
- CN202511377769.X
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2025-09-24
- Publication Date
- 2025-12-16
AI Technical Summary
Traditional DNA walkers are prone to generating false positive signals in complex biological samples, affecting the specificity and reliability of detection and limiting their application in the field of high-precision biosensing.
The supersensory molecular system employing biosignal amplification separates the walking chain from the trajectory chain and utilizes the self-folding structure of the hairpin probe H for self-protection, forming a complete walking chain only in the presence of the target, triggering a signal amplification reaction driven by the nicking endonuclease.
It effectively reduces false positive signals, improves the specificity and fidelity of detection, and achieves ultrasensitive and highly specific biomolecular detection, making it particularly suitable for high-precision detection such as ultra-low abundance biomarkers.
Smart Images

Figure CN121137124A_ABST
Abstract
Description
TECHNICAL FIELD
[0001] The present application relates to the field of biosensing technology, in particular to an ultra-sensing molecular system for biological signal amplification, a detection method and application. BACKGROUND
[0002] DNA nanotechnology is a frontier and cross field that has rapidly developed since the early 21st century. This technology uses the precise base complementary pairing characteristics and programmability of DNA molecules to construct nanoscale molecular devices and machines with specific structures and functions. Among them, DNA walker has become one of the core branches of dynamic DNA nanomachines with the most application potential because of its dual functions of "controllable movement" and "signal output". DNA walker is composed of a movable walking chain (containing a nucleic acid chain with a specific recognition sequence) and a track chain (with multiple stop sites) fixed on the interface (such as gold nanoparticles, microelectrode). Under the stimulation of enzymes, fuel chains, light or pH changes, the walking chain moves along the track chain in a directional manner, triggering the release or generation of reporter molecules (such as fluorophores, electrochemical labels) at each step, thereby realizing the cascade signal amplification of target biomolecules.
[0003] In clinical diagnosis and basic research, the accurate detection of biomarkers such as nucleic acids and low-abundance proteins is crucial, and their content in biological samples is extremely low. Traditional detection techniques such as real-time fluorescent quantitative PCR and ELISA have limitations, while DNA walker can achieve exponential signal amplification by increasing the number of walking steps, and has good biocompatibility without the need for complex sample pretreatment. It has great potential in the fields of ultra-sensitive sensing, early diagnosis of diseases, and environmental monitoring.
[0004] However, traditional DNA walkers often fix the walking chain and the track chain on the same interface (such as the surface of gold nanoparticles, microspheres or electrodes), and this natural proximity in space design easily leads to unintended binding and walking of the walking chain and the track chain without target triggering or non-specific stimulation, generating significant background signals (i.e. false positives). There are three reasons for this: first, without a target, the two may non-specifically pair due to thermal motion; second, changes in the interface microenvironment (such as surface charge, adsorbed substances) can change DNA activity and promote walking; third, in enzyme-driven walkers, enzymes may non-specifically cut the track chain after adsorption. This problem is more prominent in complex biological samples, with background signals reaching 30%-50% of target signals, or even higher, seriously affecting the reliability of detection.
[0005] The inherent defect of false positive limits the detection specificity and reliability of traditional DNA walkers in actual complex biological samples (such as serum, tissue lysate), and hinders its wide application in the field of high-precision biosensors. Therefore, developing a new type of DNA walker signal amplification strategy that can effectively overcome the problem of interface co-localization false positive, has urgent scientific significance and important application value for realizing ultra-sensitive and high-specificity biological molecule detection. SUMMARY
[0006] The purpose of the present application is to provide a biological signal amplification supersensitive molecular system, a detection method and application, which solves the problem of false positive signal of traditional DNA walker for biological signal amplification, and has good detection sensitivity and accuracy.
[0007] In order to achieve the above-mentioned purpose of the application, the present application provides the following technical solutions:
[0008] The present application provides a biological signal amplification supersensitive molecular system, comprising: a hairpin probe H and a gold nanoparticle conjugate TS@CP@AuNPs combined with the hairpin probe H;
[0009] The hairpin probe H comprises a stem sequence 1, a stem sequence 2 and a nicking endonuclease recognition sequence 1; the stem sequence 1 and the stem sequence 2 are self-complementary; the stem sequence 2 comprises a nicking endonuclease recognition sequence 2;
[0010] The gold nanoparticle conjugate TS@CP@AuNPs comprises a track chain TS and a capture chain CP;
[0011] The capture chain CP comprises a transition sequence and a capture sequence, and the capture sequence is complementary to the stem sequence 1;
[0012] The track chain TS comprises a transition sequence and a nicking endonuclease recognition sequence 3; the nicking endonuclease recognition sequence 3 is complementary to the nicking endonuclease recognition sequence 1 and the nicking endonuclease recognition sequence 2.
[0013] Preferably, the hairpin probe H further comprises a loop sequence.
[0014] Preferably, the hairpin probe H comprises, in order from 5' end to 3' end, a stem sequence 1 of 10-20 bases, a loop sequence of 6-15 bases, a stem sequence 2 of 10-20 bases, and a nicking endonuclease recognition sequence 1 of 1-5 bases; the 3' end of the stem sequence 2 comprises a nicking endonuclease recognition sequence 2 of 1-5 bases; the sequence of the stem sequence 2 excluding the nicking endonuclease recognition sequence 2 and the loop sequence are partially or completely complementary to the target sequence.
[0015] Preferably, the track chain TS comprises, in order from 5' end to 3' end, a transition sequence of 3-12 bases, a nicking endonuclease recognition sequence 3 of 7-12 bases; the nicking endonuclease recognition sequence 3 is complementary to the nicking endonuclease recognition sequence 1 and the nicking endonuclease recognition sequence 2.
[0016] Preferably, the capture chain CP comprises, in order from 3' end to 5' end, a transition sequence of 20-40 bases, a capture sequence of 10-20 bases.
[0017] Preferably, the ratio of the track chain TS to the capture chain CP loaded on the gold nanoparticles in the gold nanoparticle conjugate TS@CP@AuNPs is 1:1-20:1.
[0018] The application also provides a detection method based on the above-mentioned biological signal amplification super-sensing molecular system, comprising the following steps:
[0019] (1) mixing the sample to be detected with the hairpin probe H and the gold nanoparticle conjugate TS@CP@AuNPs uniformly, and adding a nicking endonuclease for DNA walker reaction;
[0020] (2) performing fluorescence spectrum scanning on the solution after reaction, and calculating the specific concentration of the target according to the fluorescence intensity at the maximum emission wavelength corresponding to the modified fluorescent group on the track chain TS.
[0021] Preferably, in step (1), the nicking endonuclease is an enzyme that only cuts one strand in a double-stranded substrate.
[0022] Preferably, in step (1), the enzyme that only cuts one strand in a double-stranded substrate comprises one of Nb.BbvCI endonuclease, Nt.BspQI endonuclease and Nt.AlwI endonuclease.
[0023] The application also provides an application of the above-mentioned biological signal amplification super-sensing molecular system or the above-mentioned detection method in high-precision detection, and the high-precision detection comprises high-precision detection of miRNA, cDNA or gene mutation.
[0024] Compared with the prior art, the application has the following beneficial effects:
[0025] (1) The super-sensitive molecular system for biological signal amplification of the application is composed of hairpin probe H and gold nanoparticles (TS@CP@AuNPs) loaded with track chain TS and capture chain CP. By splitting the traditional DNA walking chain into spatially isolated hairpin probe H and capture chain CP, a target-dependent activation mechanism is constructed: when there is no target, the hairpin probe H realizes self-protection through self-folding stem-loop structure, and blocks the non-specific binding of the capture chain CP / track chain TS; when the target opens the hairpin probe H, the exposed sequence hybridizes with the capture chain CP to form a complete walking chain, triggering the signal amplification reaction driven by the nicking endonuclease, and fundamentally solving the problem of false positive caused by the co-localization of the walking chain and the track chain interface. It has urgent scientific significance and important application value for realizing super-sensitive and high-specificity biological molecule detection.
[0026] (2) The super-sensitive molecular system for biological signal amplification provided by the application has good specificity and high fidelity. The self-folding structure of the hairpin probe H has natural resistance to non-target molecules, and can only be specifically opened by the target biological molecule. The subsequent formation of the complete walking chain requires target-mediated precise hybridization, which can effectively exclude non-target interference. Moreover, the walking chain cannot spontaneously assemble in the absence of the target, completely eliminating the unexpected binding and walking problem caused by the absence of the target trigger or non-specific stimulation, ensuring that the signal amplification process strictly depends on the presence of the target, realizing the precise correspondence of "signal-target", and significantly improving the specificity and fidelity of biological signal detection. It provides a more optimal technical solution for high-precision biosensing (such as ultra-low abundance biomarker detection), and has wide application prospects. BRIEF DESCRIPTION OF DRAWINGS
[0027] In order to more clearly illustrate the technical solutions in the embodiments of the application or the prior art, the drawings needed in the embodiments will be briefly introduced below. Obviously, the drawings in the following description are only some embodiments of the application, and other drawings can be obtained by those skilled in the art without creative labor.
[0028] Figure 1 The detection principle of the super-sensitive molecular system for biological signal amplification in Example 1 of the application;
[0029] Figure 2 The absorption spectrum of the DNA chain before and after coupling with gold nanoparticles in Example 2 of the application;
[0030] Figure 3 The fluorescence detection results of the target sequence (miR-21) and the control group in Example 2 of the application, wherein a is the detection fluorescence intensity curve of the target sequence (miR-21), and b is the fluorescence intensity column chart of the target sequence (miR-21) detection;
[0031] Figure 4 The results of fluorescence detection of the target sequence (miR-141) and the control group in Example 3 of the present invention are shown, where a is the fluorescence intensity curve of the target sequence (miR-141) and b is the bar chart of the fluorescence intensity of the target sequence (miR-141).
[0032] Figure 5 The results of fluorescence detection of the target sequence (miR-199a) and the control group in Example 4 of the present invention are shown, where a is the fluorescence intensity curve of the target sequence (miR-199a) and b is the fluorescence intensity bar graph of the target sequence (miR-199a).
[0033] Figure 6 The results of single-base gene mutation (KRAS G12D) detection in Example 5 of the present invention are shown in Figure a, where a is the fluorescence intensity curve of single-base gene mutation (KRAS G12D) detection and b is the fluorescence intensity bar graph of single-base gene mutation (KRAS G12D) detection.
[0034] Figure 7 This is a schematic diagram of the principle of a conventional DNA walking machine in the experimental examples of this invention;
[0035] Figure 8 This is a comparison chart of the detection results of Example 2 in the test cases of the present invention and the traditional technology. Detailed Implementation
[0036] Various exemplary embodiments of the present invention will now be described in detail. This detailed description should not be considered as a limitation of the present invention, but rather as a more detailed description of certain aspects, features, and embodiments of the present invention.
[0037] It should be understood that the terminology used in this invention is merely for describing particular embodiments and is not intended to limit the invention. Furthermore, with respect to numerical ranges in this invention, it should be understood that each intermediate value between the upper and lower limits of the range is also specifically disclosed. Every smaller range between any stated value or intermediate value within a stated range, and any other stated value or intermediate value within said range, is also included in this invention. The upper and lower limits of these smaller ranges may be independently included or excluded from the range.
[0038] Unless otherwise stated, all technical and scientific terms used herein have the same meaning as commonly understood by one of ordinary skill in the art. While only preferred methods and materials have been described herein, any methods and materials similar or equivalent to those described herein may be used in the implementation or testing of this invention. All references to this specification are incorporated by way of citation to disclose and describe methods and / or materials associated with those references. In the event of any conflict with any incorporated reference, the content of this specification shall prevail.
[0039] Various modifications and variations can be made to the specific embodiments described in this specification without departing from the scope or spirit of the invention, as will be apparent to those skilled in the art. Other embodiments derived from this specification will also be apparent to those skilled in the art. This specification and embodiments are merely exemplary.
[0040] The terms “include,” “including,” “have,” “contain,” etc., used in this article are all open-ended terms, meaning that they include but are not limited to.
[0041] This invention provides a detection method for ultrasensory molecular systems based on biosignal amplification, comprising the following steps:
[0042] (1) Mix the sample to be tested with the hairpin probe H and the conjugate TS@CP@AuNPs evenly, and add a nicking endonuclease to perform a DNAwalker reaction; wherein the nicking endonuclease is an enzyme that cuts only one strand of the double-stranded substrate, more preferably one of Nb.BbvCI endonuclease, Nt.BspQI endonuclease, and Nt.AlwI endonuclease. The amount of nicking endonuclease added is 5-20 U, the DNAwalker reaction temperature is 25-50℃, and the reaction time is 0.5-4 h.
[0043] The sample to be tested is a sample that has undergone pretreatment, which includes DNA / RNA extraction and DNA / RNA amplification; the final concentration of the hairpin probe H is 10-500 nM, and the final concentration of the conjugate TS@CP@AuNPs is 1-10 nM.
[0044] (2) Perform fluorescence spectroscopy scanning on the solution after the reaction, and calculate the specific concentration of the target based on the fluorescence intensity at the maximum emission wavelength corresponding to the fluorescent group modified on the TS trajectory chain.
[0045] Example 1
[0046] Example 1 of this invention provides a method for preparing a supersensory molecular system for amplifying biological signals, the specific steps of which are as follows:
[0047] (1) Sequence Design
[0048] Based on the gene to be tested, design the hairpin probe H, the capture strand CP, and the trajectory strand TS according to the following requirements:
[0049] Hairpin probe H: From the 5' end to the 3' end, it includes a stem sequence 1 of 10-20 bases, a loop sequence of 6-15 bases, a stem sequence 2 of 10-20 bases, and a nicking endonuclease recognition sequence 1 of 1-5 bases; the 3' end of the stem sequence 2 includes a nicking endonuclease recognition sequence 2 of 1-5 bases; the stem sequence 1 and the stem sequence 2 are self-complementary; the loop sequence and the stem sequence 2 (excluding the nicking endonuclease recognition sequence 2) are partially or completely complementary to the target sequence.
[0050] The trapping chain CP is modified with a thiol group at the 3' end and includes a transition sequence of 20-40 bases and a trapping sequence of 10-20 bases from the 3' end to the 5' end; the trapping sequence is complementary to the stem sequence 1.
[0051] The trajectory chain TS is modified with a thiol group at the 5' end and a fluorescent group at the 3' end. It includes a transition sequence of 3 to 12 bases from the 5' end to the 3' end, and a nicking endonuclease recognition sequence 3 of 7 to 12 bases. The nicking endonuclease recognition sequence 3 is complementary to the nicking endonuclease recognition sequence 1 and the nicking endonuclease recognition sequence 2.
[0052] (2) Preparation of the coupling compound TS@CP@AuNPs:
[0053] 5 μL (10 μM) of the capture chain CP aqueous solution and 5 μL (100 μM) of the trajectory chain TS aqueous solution were added to 1 mL of AuNPs aqueous solution (1 nM), vortexed to mix well, and frozen at -20 °C for 2 h. After thawing at room temperature, the mixture was centrifuged at 15000 rpm / min for 30 min, the supernatant was discarded, and the precipitate was washed three times by centrifugation (15000 rpm / min, 5 min) with PBST buffer (8 mM Na2HPO4, 2 mM KH2PO4, 10 mM KCl, 140 mM NaCl, 0.05% Tween-20, pH 7.2–7.4). The precipitate was resuspended in cleavage enzyme buffer to obtain the covalently coupled gold nanoparticles TS@CP@AuNPs with CP and TS.
[0054] (3) By integrating TS@CP@AuNPs and hairpin probe H into the same system, a supersensory molecular system for amplifying biosignals is obtained. The detection principle of this supersensory molecular system for amplifying biosignals is as follows: Figure 1 As shown.
[0055] Example 2
[0056] Embodiment 2 of the present invention detects miR-21 based on the method of Embodiment 1, and the specific steps are as follows:
[0057] (1) Sequence Design
[0058] Referring to the sequence design requirements of Example 1, a sequence for detecting miR-21 was designed, and the specific sequences are shown in Table 1:
[0059] Table 1 miR-21 related detection sequences
[0060]
[0061] Note: The underlined part is either stem sequence 1 or stem sequence 2.
[0062] (2) Preparation of the coupling compound TS@CP@AuNPs:
[0063] Following the steps in Example 1, conjugates TS@CP@AuNPs were prepared using the sequences in Table 1, and the absorbance of the conjugates TS@CP@AuNPs in this example was measured. The results are as follows: Figure 2 As shown.
[0064] Due to the quantum size effect, the maximum absorption wavelength of plasmon resonance absorption on the surface of metal particles redshifts as the particle size increases. Figure 2 The results showed that after the gold nanoparticles were coupled with DNA, the maximum absorption wavelength was red-shifted by 4-6 nm in the ultraviolet spectrum, proving that the coupling was successful.
[0065] (3) miR-21 detection
[0066] Nb.BbvCI restriction enzyme buffer solution: 50mM K2CO3, 20mM Tris-H2CO3, 10mM MgCO3, 100μg / ml recombinant albumin, pH 7.9, 25℃.
[0067] 200 μL reaction systems were prepared for the miR-21 group and the blank control group using Nb.BbvCI restriction enzyme buffer. The final concentrations of each component in the miR-21 group were: 50 nM target sequence (SEQ ID NO.1), 200 nM hairpin probe H, 4 nM conjugate TS@CP@AuNPs, and 10 U Nb.BbvCI restriction enzyme. The blank control group did not include the target sequence. Both the miR-21 group and the blank control group were incubated at 37 °C for 2 hours.
[0068] The reaction solution was transferred to a microcuvette after the reaction was completed, and a fluorescence spectrophotometer was used for spectral scanning. The excitation wavelength was 490 nm, the excitation / emission slit width was 5 nm, and the emission spectrum from 500 to 600 nm and the fluorescence intensity at 518 nm were collected. The results are as follows: Figure 3 As shown.
[0069] Figure 3The results showed that the fluorescence intensity of the miR-21 group was significantly higher than that of the blank group, proving that the molecular machine was successfully driven when the target sequence was present, a large number of fluorescent groups were cleaved, and the solution produced fluorescence. The blank group showed low fluorescence, proving that no obvious false positive signals were generated.
[0070] Example 3
[0071] Embodiment 3 of the present invention detects miR-141 based on the method of Embodiment 1. The specific steps are as follows:
[0072] (1) Sequence Design
[0073] Referring to the sequence design requirements of Example 1, a sequence for detecting miR-141 was designed, and the specific sequence is shown in Table 2:
[0074] Table 2 miR-141 related detection sequences
[0075]
[0076] (2) Preparation of the coupling compound TS@CP@AuNPs:
[0077] Following the steps in Example 1, conjugates TS@CP@AuNPs were prepared using the sequences in Table 2.
[0078] (3) Detection
[0079] 200 μL reaction systems were prepared for the miR-141 group and the blank control group using Nb.BbvQI restriction enzyme buffer (100 mM NaCl, 50 mM Tris-HCl, 10 mM MgCl2, 100 μg / ml recombinant albumin, pH 7.9, 25℃). The final concentrations of each component in the miR-141 group were: 100 nM target sequence (SEQ ID NO.5), 150 nM hairpin probe H, 3 nM conjugate TS@CP@AuNPs, and 5 Nb.BbvQI restriction enzyme. The blank control group did not include the target sequence. The miR-141 group and the blank control group were incubated at 45℃ for 1.5 hours.
[0080] The reaction solution was transferred to a microcuvette after the reaction was completed, and a fluorescence spectrophotometer was used for spectral scanning. The excitation wavelength was 490 nm, the excitation / emission slit width was 5 nm, and the emission spectrum from 500 to 600 nm and the fluorescence intensity at 518 nm were collected. The results are as follows: Figure 4 As shown.
[0081] Figure 4The results showed that the fluorescence intensity of the target sequence (miR-141) group was significantly higher than that of the blank group, proving that the molecular machine was successfully driven when the target sequence was present, a large number of fluorescent groups were cleaved, and the solution produced fluorescence. The blank group showed low fluorescence, proving that no obvious false positive signals were generated.
[0082] Example 4
[0083] Example 4 of this invention detects miR-199a based on the method of Example 1. The specific steps are as follows:
[0084] (1) Sequence Design
[0085] Referring to the sequence design requirements of Example 1, a sequence for detecting miR-199a was designed, and the specific sequence is shown in Table 3:
[0086] Table 3 miR-199a related detection sequences
[0087]
[0088] (2) Preparation of the coupling compound TS@CP@AuNPs:
[0089] Following the steps in Example 1, conjugates TS@CP@AuNPs were prepared using the sequences in Table 3.
[0090] (3) Detection
[0091] 200 μL reaction systems were prepared for the miR-199a group and the blank control group using Nb.AlwI restriction enzyme buffer (50 mM K2CO3, 20 mM Tris-H2CO3, 10 mM MgCO3, 100 μg / ml recombinant albumin, pH 7.9, 5℃). The final concentrations of each component in the miR-199a group were: 25 nM target sequence (SEQ ID NO. 9), 250 nM hairpin probe H, 5 nM conjugates TS@CP@AuNPs, and 15 U Nb.AlwI restriction enzyme. The blank control group did not include the target sequence. The miR-199a group and the blank control group were incubated at 37℃ for 2 hours.
[0092] The reaction solution was transferred to a microcuvette after the reaction was completed, and a fluorescence spectrophotometer was used for spectral scanning. The excitation wavelength was 490 nm, the excitation / emission slit width was 5 nm, and the emission spectrum from 500 to 600 nm and the fluorescence intensity at 518 nm were collected. The results are as follows: Figure 5 As shown.
[0093] Figure 5The results showed that the fluorescence intensity of the target sequence (miR-199a) group was significantly higher than that of the blank group, proving that the molecular machine was successfully driven when the target sequence was present, a large number of fluorescent groups were cleaved, and the solution produced fluorescence. The blank group showed low fluorescence, proving that no obvious false positive signals were generated.
[0094] Example 5
[0095] Example 5 of this invention detects single-base gene mutations (KRAS G12D) based on the method of Example 1. The specific steps are as follows:
[0096] (1) Sequence Design
[0097] Referring to the sequence design requirements of Example 1, a sequence for detecting single-base gene mutations (KRAS G12D) was designed, and the specific sequences are shown in Table 4:
[0098] Table 4. Detection sequences related to single-base gene mutations (KRAS G12D)
[0099]
[0100] (2) Preparation of the coupling compound TS@CP@AuNPs:
[0101] Following the steps in Example 1, conjugates TS@CP@AuNPs were prepared using the sequences in Table 4.
[0102] (3) Sample pretreatment
[0103] Using Ampligase DNA Ligase buffer (20 mM Tris-HCl, 25 mM KCl, 10 mM MgCl2, 0.5 mM NAD and 0.01%) Prepare 100 μL of reaction solution using X-100. The reaction solution includes: 50 nM primer / probe A, 50 nM primer / probe B, 10 nM target sequence (target sequence mutant or target sequence wild type), and 2.5 U Ampligase DNA Ligase. After thorough mixing, perform the following temperature cycling program: 95℃→30 s, 4℃→30 s, 60℃→1 min, for 60 cycles.
[0104] (4) Detection of single-base gene mutation (KRAS G12D)
[0105] 200 μL reaction systems were prepared for both the mutant and wild-type groups using pretreated sample solutions. The concentrations of each component in both groups were as follows: 50 mM K₂CO₃, 20 mM Tris-H₂CO₃, 10 mM MgCO₃, 100 μg / mL recombinant albumin, 200 nM hairpin probe H, 4 nM conjugates TS@CP@AuNPs, and 15 U Nb.BbvCI restriction enzyme. The mutant and wild-type reaction solutions were incubated at 37°C for 1 hour.
[0106] The reaction solution was transferred to a microcuvette after the reaction was completed, and a fluorescence spectrophotometer was used for spectral scanning. The excitation wavelength was 490 nm, the excitation / emission slit width was 5 nm, and the emission spectrum from 500 to 600 nm and the fluorescence intensity at 518 nm were collected. The results are as follows: Figure 6 As shown.
[0107] Figure 6 The results showed that the fluorescence intensity of the target sequence mutant group was significantly higher than that of the target sequence wild-type group, proving that the molecular machine was successfully driven when the target sequence mutant was present, a large number of fluorescent groups were cleaved, and the solution produced fluorescence. The target sequence wild-type group, on the other hand, exhibited low fluorescence, indicating that no obvious false positive signals were generated.
[0108] Test case
[0109] The experimental examples of this invention use the traditional DNAwalker (principle as follows) Figure 7 The miR-21 was detected using the technique shown in Example 2, with specific steps as follows:
[0110] (1) Traditional DNA Walker sequence design is shown in Table 5:
[0111] Table 5 Traditional DNA Walker Sequences
[0112]
[0113] (2) TS@WS@AuNPs were prepared according to Example 1. A 200 μL reaction system was prepared using 1×PBS buffer, which included 4 nM of conjugate TS@WS@AuNPs and 400 nM of auxiliary ligand S. The system was reacted for 1 h, and then centrifuged and washed three times with BST buffer at 15000 rpm / min for 5 min. The mixture was then resuspended in nicking restriction enzyme buffer to obtain the traditional DNA walker reaction substrate TS@WS@S@AuNPs.
[0114] The reacted solution was transferred to a micro-cubic cell, and a fluorescence spectrophotometer was used for spectral scanning. The excitation wavelength was 490 nm, the excitation / emission slit width was 5 nm, and the emission spectrum from 500 to 600 nm and the fluorescence intensity at 518 nm were collected.
[0115] Compared with the detection results of Example 2, the results are as follows: Figure 8 As shown.
[0116] Figure 8 The results show that the present invention has a higher true positive signal, a lower false positive signal, and a higher discrimination factor (discrimination factor = true signal / false positive signal). Therefore, compared with the prior art, the present invention has better detection sensitivity and specificity.
[0117] The above description is only a preferred embodiment of the present invention. It should be noted that for those skilled in the art, several improvements and modifications can be made without departing from the principle of the present invention, and these improvements and modifications should also be considered within the scope of protection of the present invention.
Claims
1. A supersensory molecular system for amplifying biological signals, characterized in that, include: Hairpin probe H and gold nanoparticle conjugates TS@CP@AuNPs bound to hairpin probe H; The hairpin probe H includes stem sequence 1, stem sequence 2, and nicking endonuclease recognition sequence 1; stem sequence 1 and stem sequence 2 are self-complementary; stem sequence 2 includes nicking endonuclease recognition sequence 2; The gold nanoparticle conjugates TS@CP@AuNPs include a trajectory chain TS and a trapping chain CP; The capture chain CP includes a transition sequence and a capture sequence, wherein the capture sequence is complementary to the stem sequence 1; The trajectory chain TS includes a transition sequence and a nicking endonuclease recognition sequence 3; the nicking endonuclease recognition sequence 3 is complementary to the nicking endonuclease recognition sequence 1 and the nicking endonuclease recognition sequence 2.
2. The ultrasensory molecular system for amplifying biosignals according to claim 1, characterized in that, The hairpin probe H also includes a ring sequence.
3. The ultrasensory molecular system for amplifying biosignals according to claim 2, characterized in that, The hairpin probe H comprises, from its 5' end to its 3' end, a stem sequence 1 of 10-20 bases, a loop sequence of 6-15 bases, a stem sequence 2 of 10-20 bases, and a nicking endonuclease recognition sequence 1 of 1-5 bases; the 3' end of the stem sequence 2 includes a nicking endonuclease recognition sequence 2 of 1-5 bases; the stem sequence 2 does not include the nicking endonuclease recognition sequence 2 and the loop sequence, which are partially or completely complementary to the target sequence.
4. The ultrasensory molecular system for amplifying biosignals according to claim 1, characterized in that, The trajectory chain TS includes a transition sequence of 3 to 12 bases from the 5' end to the 3' end, and a nicking endonuclease recognition sequence 3 of 7 to 12 bases; the nicking endonuclease recognition sequence 3 is complementary to the nicking endonuclease recognition sequence 1 and the nicking endonuclease recognition sequence 2.
5. The ultrasensory molecular system for amplifying biosignals according to claim 1, characterized in that, The capture chain CP includes a transition sequence of 20-40 bases and a capture sequence of 10-20 bases from the 3' end to the 5' end.
6. The ultrasensory molecular system for amplifying biosignals according to claim 1, characterized in that, In the gold nanoparticle conjugates TS@CP@AuNPs, the loading ratio of the trajectory chain TS to the trapping chain CP on the gold nanoparticles is 1:1 to 20:
1.
7. A detection method based on the ultrasensory molecular system with biosignal amplification as described in any one of claims 1 to 6, characterized in that, Includes the following steps: (1) Mix the sample to be tested with hairpin probe H and gold nanoparticle conjugate TS@CP@AuNPs evenly, and add nicking endonuclease to carry out DNA walker reaction; (2) Perform fluorescence spectroscopy scanning on the solution after the reaction, and calculate the specific concentration of the target based on the fluorescence intensity at the maximum emission wavelength corresponding to the fluorescent group modified on the trajectory chain TS.
8. The detection method according to claim 7, characterized in that, In step (1), the cleavage endonuclease is one of the enzymes that cleaves only one strand of a double-stranded substrate.
9. The detection method according to claim 8, characterized in that, In step (1), the enzyme that cuts only one strand of the double-stranded substrate includes Nb.BbvCI endonuclease, Nt.BspQI endonuclease, and Nt.AlwI endonuclease.
10. The application of the ultrasensory molecular system for biosignal amplification according to any one of claims 1 to 6 or the detection method according to any one of claims 7 to 9 in high-precision detection, characterized in that, The high-precision detection includes high-precision detection of miRNA, cDNA, or gene mutations.
